Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28647
Title: Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary?
Austin Authors: Peterson, Adam R;Hilley, Patrick ;De Cruz, Peter P 
Affiliation: Medicine (University of Melbourne)..
Gastroenterology and Hepatology..
Issue Date: 30-Mar-2022
Date: 2022
Publication information: Inflammatory bowel diseases 2022; 28(4): e46
URI: https://ahro.austin.org.au/austinjspui/handle/1/28647
DOI: 10.1093/ibd/izab356
ORCID: 0000-0002-9398-965X
Journal: Inflammatory bowel diseases
PubMed URL: 35045169
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35045169/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Apr 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.